Novartis Sverige

Novartis Sverige company information, Employees & Contact Information

Explore related pages

Related company profiles:

Novartis arbetar för att skapa mervärde för patienter och våra samarbetspartners inom sjukvården. Vi vill påverka människors liv i en positiv riktning genom att upptäcka, utveckla och marknadsföra nya produkter för att bota sjukdomar och förbättra människors livskvalitet. Novartis arbetar för att vara en attraktiv arbetsplats där våra medarbetare kan utvecklas och där kreativitet uppmuntras. Vi har höga etiska krav och engagerar oss i vår omvärld och det samhälle där vi verkar. Läs våra community guidelines och meddelande om skydd av personuppgifter för LinkedIn här: https://www.novartis.com/se-se/community-guidelines-novartis-linkedin-sidor SE2308303693 (30 augusti 2023)

Company Details

Employees
41
Address
Torshamnsgatan 48, Plan 9,sweden
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Kista, Stockholm
Looking for a particular Novartis Sverige employee's phone or email?

Novartis Sverige Questions

News

The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne - Yahoo Finance

The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne Yahoo Finance

Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance - Placera.se

Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance Placera.se

Novartis names Mehta new CFO - BioCentury

Novartis names Mehta new CFO BioCentury

Novartis beats Q4 earnings consensus as drug sales surge - Reuters

Novartis beats Q4 earnings consensus as drug sales surge Reuters

$802 Million Brain Drug Breakthrough: BioArctic's Technology Could Transform Neurological Treatment Delivery - Stock Titan

$802 Million Brain Drug Breakthrough: BioArctic's Technology Could Transform Neurological Treatment Delivery Stock Titan

Top Stock Reports for SAP, Novartis & Philip Morris - Yahoo Finance

Top Stock Reports for SAP, Novartis & Philip Morris Yahoo Finance

WIN Consortium leading the future of precision cancer medicine - EurekAlert!

WIN Consortium leading the future of precision cancer medicine EurekAlert!

Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots - statnews.com

Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots statnews.com

Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal - Fierce Pharma

Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal Fierce Pharma

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG - Placera.se

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG Placera.se

BioNTech says Novartis executive Zapata-Gomez to become CFO - Reuters

BioNTech says Novartis executive Zapata-Gomez to become CFO Reuters

Sickle cell disease - Novartis

Sickle cell disease Novartis

Two phase III wins for Novartis in autoimmune diseases - BioWorld MedTech

Two phase III wins for Novartis in autoimmune diseases BioWorld MedTech

Generate and Novartis partner for protein therapeutics development - Pharmaceutical Technology

Generate and Novartis partner for protein therapeutics development Pharmaceutical Technology

Novartis ranks first in 2024 Access to Medicine Index - Novartis

Novartis ranks first in 2024 Access to Medicine Index Novartis

ESMO: Novartis' booming Pluvicto posts mixed results in earlier prostate cancer - Fierce Pharma

ESMO: Novartis' booming Pluvicto posts mixed results in earlier prostate cancer Fierce Pharma

Eden Wells to lead insights and decision science at Novartis - BioCentury

Eden Wells to lead insights and decision science at Novartis BioCentury

Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments - Novartis

Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments Novartis

BioNTech buys Novartis plant in Singapore, will retrofit for mRNA vaccine production - Fierce Pharma

BioNTech buys Novartis plant in Singapore, will retrofit for mRNA vaccine production Fierce Pharma

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response - Novartis

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response Novartis

Novartis cuts top commercial title, replaces departing exec Marie-France Tschudin with AbbVie vet Patrick Horber - Fierce Pharma

Novartis cuts top commercial title, replaces departing exec Marie-France Tschudin with AbbVie vet Patrick Horber Fierce Pharma

A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea - Nature

A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea Nature

ITM promotes supply deal with Novartis for Pluvicto - AuntMinnie

ITM promotes supply deal with Novartis for Pluvicto AuntMinnie

Novartis buying Tourmaline and its anti-IL-6 cardio drug for $1.4B - BioWorld MedTech

Novartis buying Tourmaline and its anti-IL-6 cardio drug for $1.4B BioWorld MedTech

BioNTech says Novartis executive Zapata-Gomez to become CFO - PharmaLive

BioNTech says Novartis executive Zapata-Gomez to become CFO PharmaLive

Novartis announced that it will not produce the famous antibiotic Tobrex until the end of May - Free Press - Слободен печат

Novartis announced that it will not produce the famous antibiotic Tobrex until the end of May - Free Press Слободен печат

BioArctic AB Sees Growth with Leqembi® and Novartis Partnership - TipRanks

BioArctic AB Sees Growth with Leqembi® and Novartis Partnership TipRanks

ESMO 2023 – Pluvicto’s big splash gets an early preview | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

ESMO 2023 – Pluvicto’s big splash gets an early preview | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Novartis Signs Pact to Help Produce Pfizer-BioNTech Vaccine - Bloomberg

Novartis Signs Pact to Help Produce Pfizer-BioNTech Vaccine Bloomberg

Novartis mulls spinning off ophthalmology and respiratory divisions - drugdiscoverytrends.com

Novartis mulls spinning off ophthalmology and respiratory divisions drugdiscoverytrends.com

BioArctic Partners with Novartis for Neurodegeneration Treatment - TipRanks

BioArctic Partners with Novartis for Neurodegeneration Treatment TipRanks

At €200 Billion, Hermes Surfs Luxury Boom to Surpass Novartis - Bloomberg

At €200 Billion, Hermes Surfs Luxury Boom to Surpass Novartis Bloomberg

Novartis in Talks to Join Pharma Industry’s Covid Vaccine Push - Bloomberg

Novartis in Talks to Join Pharma Industry’s Covid Vaccine Push Bloomberg

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion - Benzinga

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion Benzinga

Ebadollahi leaving Novartis as chief data and AI officer - BioCentury

Ebadollahi leaving Novartis as chief data and AI officer BioCentury

Recordati and Novartis’ Isturisa Approved for Cushing’s Disease - BioSpace

Recordati and Novartis’ Isturisa Approved for Cushing’s Disease BioSpace

Top 20 Pharmaceutical Companies - Opportimes

Top 20 Pharmaceutical Companies Opportimes

Novartis sets sights on high-value medicines and US market - SWI swissinfo.ch

Novartis sets sights on high-value medicines and US market SWI swissinfo.ch

CAR T deal puts focus on Elicera's technology - Biostock

CAR T deal puts focus on Elicera's technology Biostock

Implantable Cancer Vaccine - Wyss Institute at Harvard

Implantable Cancer Vaccine Wyss Institute at Harvard

Novartis scraps sale of assets including COVID-19 hopeful to Aurobindo Pharma - Yahoo! Finance Singapore

Novartis scraps sale of assets including COVID-19 hopeful to Aurobindo Pharma Yahoo! Finance Singapore

Amy C. Edmondson - Harvard Business School

Amy C. Edmondson Harvard Business School

EU Rules on Repackaging Pharmaceuticals - Jones Day

EU Rules on Repackaging Pharmaceuticals Jones Day

ITM Appoints Roger Estafanos as U.S. General Manager and - GlobeNewswire

ITM Appoints Roger Estafanos as U.S. General Manager and GlobeNewswire

Mundipharma, Novartis to distribute pain medicine in SE Asia - BioSpectrum Asia

Mundipharma, Novartis to distribute pain medicine in SE Asia BioSpectrum Asia

Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer - NTB Kommunikasjon

Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer NTB Kommunikasjon

Applying machine learning to challenges in the pharmaceutical industry - MIT News

Applying machine learning to challenges in the pharmaceutical industry MIT News

BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties - Finansavisen

BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties Finansavisen

Prolight Diagnostics’ CTO highlights the potential of the Psyros system - Biostock

Prolight Diagnostics’ CTO highlights the potential of the Psyros system Biostock

ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer - Imaging Technology News

ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer Imaging Technology News

Swiss companies Novartis and Adecco commit to hiring refugees - SWI swissinfo.ch

Swiss companies Novartis and Adecco commit to hiring refugees SWI swissinfo.ch

Is This the Anti-Aging Pill We’ve All Been Waiting For? - MIT Technology Review

Is This the Anti-Aging Pill We’ve All Been Waiting For? MIT Technology Review

Lipid Management Center established in collaboration between Semmelweis University and Novartis - Semmelweis Egyetem

Lipid Management Center established in collaboration between Semmelweis University and Novartis Semmelweis Egyetem

Protein degradation pathways – Helin Norberg's research group - Karolinska Institutet

Protein degradation pathways – Helin Norberg's research group Karolinska Institutet

Novartis Buys MorphoSys for €2.7 Billion to Get Cancer Drugs - Finance.si

Novartis Buys MorphoSys for €2.7 Billion to Get Cancer Drugs Finance.si

Top Novartis Sverige Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant